Concepedia

Chee-Keng Ng

CN

Statistics

Publications

2

Citations

89

H-Index

2

Active since

2014

Affiliations

Covance (United States)(Current)

Pfizer (United States)

Chee-Keng Ng is an author at Covance (United States) specializing in molecular pharmacology, pre-clinical pharmacology, and pharmacodynamic modeling.

Top concepts

Publications per year

2014–2014

2

Publications

2

Comparative Nonclinical Assessments of the Proposed Biosimilar PF-05280014 and Trastuzumab (Herceptin®)

Susan Hurst, Anne Ryan, Chee-Keng Ng et al. · BioDrugs · 2014 · 47 citations · Full text

Comparative Nonclinical Assessments of the Proposed Biosimilar PF-05280586 and Rituximab (MabThera®)

Anne Ryan, Sharon Sokolowski, Chee-Keng Ng et al. · Toxicologic Pathology · 2014 · 42 citations

, , +22

1–2 of 2